Company news

Mayne Pharma Group Ltd. news in 2025

Mayne Pharma Group Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Market Update

December 21, 2025

Termination of Proposed Acquisition of Mayne Pharma

December 11, 2025

Mayne Pharma terminates Scheme Implementation Deed

December 10, 2025

MYX receives purported termination notice from Cosette

December 9, 2025

Mayne Pharma issues notice of intention to terminate the SID

December 3, 2025

Update on FIRB condition and scheme

November 21, 2025

Trading Halt

November 20, 2025

Pause in Trading

November 20, 2025

Update on status of FIRB approval and second court hearing

November 20, 2025

MYX Declaration of Unacceptable Circumstances and Orders

November 19, 2025

Update on FIRB approval and Scheme

November 17, 2025

MYX - Panel Conducts Proceedings and Makes Interim Orders

November 14, 2025

Update on Scheme and Supreme Court of NSW proceedings

November 10, 2025

MYX Scheme of Arrangement update on FIRB approval

October 30, 2025

Outcome of litigation and update on Scheme

October 15, 2025

MYX announces PBS listing of NEXTSTELLIS in Australia

September 29, 2025

Mayne Pharma addresses recent media articles regarding FIRB

September 7, 2025

2025 Full Year Results Investor Presentation

August 28, 2025

2025 Full Year Results Media Release

August 28, 2025

Full Year Statutory Accounts

August 28, 2025

Results of Scheme Meeting

June 18, 2025

Chair's address and presentation at the Scheme Meeting

June 17, 2025

Update on litigation with Cosette

June 15, 2025

Supplementary Scheme Booklet

June 4, 2025

Mayne Pharma receives purported notice to terminate SID

June 4, 2025

Update on Scheme of Arrangement with Cosette

June 3, 2025

Response to ASX Aware Letter

May 21, 2025

Update on Scheme with Cosette

May 20, 2025

ASIC registration of Mayne Pharma scheme booklet

May 15, 2025

Court approves convening of scheme meeting

May 15, 2025

Response to ASX Price Query

May 14, 2025

Pause in Trade

May 14, 2025

Response to ASX Query

May 11, 2025

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

April 17, 2025

2025 Half Year Investor Presentation

February 25, 2025

2025 Half Year Media Release

February 25, 2025

Mayne Pharma enters Scheme Implementation Deed with Cosette

February 20, 2025

Mayne Pharma market update

February 9, 2025

Decks in 2025